The role of HDL-cholesterol in preventing atherosclerotic disease

被引:81
作者
Barter, P [1 ]
机构
[1] Heart Res Inst, Camperdown, NSW 2050, Australia
关键词
HDL-cholesterol; atherosclerosis; inflammation; cardiovascular risk; dyslipidaemia;
D O I
10.1093/eurheartj/sui036
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
The cholesterol required by peripheral tissues, including vascular cells, is provided both by new synthesis in the cells and by a delivery from low-density lipoproteins (LDLs). When the level of LDLs is high, they accumulate in the artery wall where they are oxidized and taken up by foam cells in a process that leads to the development and progression of atherosclerosis. High-density lipoproteins (HDLs) oppose atherosclerosis directly, by removing cholesterol from foam cells, by inhibiting the oxidation of LDLs, and by limiting the inflammatory processes that underlie atherosclerosis. HDLs also have antithrombotic properties. Thus, HDL-cholesterol interrupts the process of atherogenesis at several key stages.
引用
收藏
页码:F4 / F8
页数:5
相关论文
共 27 条
[1]
Metabolic abnormalities: high-density lipoproteins [J].
Barter, P .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2004, 33 (02) :393-+
[2]
Cholesteryl ester transfer protein - A novel target for raising HDL and inhibiting atherosclerosis [J].
Barter, PJ ;
Brewer, HB ;
Chapman, MJ ;
Hennekens, CH ;
Rader, DJ ;
Tall, AR .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (02) :160-167
[3]
Elevated soluble cellular adhesion molecules in subjects with low HDL-cholesterol [J].
Calabresi, L ;
Gomaraschi, M ;
Villa, B ;
Omoboni, L ;
Dmitrieff, C ;
Franceschini, G .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (04) :656-661
[4]
INCIDENCE OF CORONARY HEART-DISEASE AND LIPOPROTEIN CHOLESTEROL LEVELS - THE FRAMINGHAM-STUDY [J].
CASTELLI, WP ;
GARRISON, RJ ;
WILSON, PWF ;
ABBOTT, RD ;
KALOUSDIAN, S ;
KANNEL, WB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (20) :2835-2838
[5]
Time sequence of the inhibition of endothelial adhesion molecule expression by reconstituted high density lipoproteins [J].
Clay, MA ;
Pyle, DH ;
Rye, KA ;
Vadas, MA ;
Gamble, JR ;
Barter, PJ .
ATHEROSCLEROSIS, 2001, 157 (01) :23-29
[6]
HIGH-DENSITY-LIPOPROTEINS INHIBIT CYTOKINE-INDUCED EXPRESSION OF ENDOTHELIAL-CELL ADHESION MOLECULES [J].
COCKERILL, GW ;
RYE, KA ;
GAMBLE, JR ;
VADAS, MA ;
BARTER, PJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (11) :1987-1994
[7]
High-density lipoproteins differentially modulate cytokine-induced expression of E-selectin and cyclooxygenase-2 [J].
Cockerill, GW ;
Saklatvala, J ;
Ridley, SH ;
Yarwood, H ;
Miller, NE ;
Oral, B ;
Nithyanathan, S ;
Taylor, G ;
Haskard, DO .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (04) :910-917
[8]
Cockerill GW, 2001, CIRCULATION, V103, P108
[9]
LIPOPOLYSACCHARIDE-INDUCED MONOCYTE PROCOAGULANT ACTIVITY, FIBRINOPEPTIDE-A, AND PAI-I LEVELS IN PERSONS WITH HIGH OR LOW-LEVELS OF HDL-LIPOPROTEIN [J].
EGGESBO, JB ;
HJERMANN, I ;
HOSTMARK, AT ;
JOO, GB ;
KIERULF, P .
THROMBOSIS RESEARCH, 1993, 70 (02) :161-171
[10]
Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality - A 21-year follow-up of 8000 men [J].
Goldbourt, U ;
Yaari, S ;
Medalie, JH .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (01) :107-113